HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Rivella Laboratory News & Announcements
1 - 8 of 8
Published on Jul 30, 2025 in Cornerstone Blog
CHOP researchers found that the cytokine TNFα helped to resolve inflammation in a preclinical model.
Published on Apr 15, 2025 in Cornerstone Blog
In this Q&A, Dr. Kwiatkowski talks about her new clinical trial for a CHOP developed gene therapy for beta thalassemia.
Published on Jul 1, 2024 in Press Releases
Researchers at CHOP and the University of Pennsylvania Perelman School of Medicine pioneered a new model that offers a potential platform for developing novel therapies to treat Alpha Thalassemia.
Published on Jul 31, 2023 in Cornerstone Blog
Researchers developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification of diseased blood cells directly within the body.
Published on Jun 1, 2022 in Cornerstone Blog
The Featured Research Staff Member for PRIDE Month is Carlo Castruccio Castracani.
Published on Jun 2, 2021 in Cornerstone Blog
Stefano Rivella, PhD, is developing a new gene therapy — a multitasking vector — for treatment of red blood disorders.
Published on Feb 1, 2021 in Cornerstone Blog
CHOP researchers have developed a potentially safer and more effective gene therapy vector for red blood disorders.
Published on Jan 29, 2021 in Press Releases
The vector minimizes the risk of toxic side effects.